Environmental News Network - New Study Shows Mathematical Models Helped Reduce the Spread of COVID-19 in Colorado enn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from enn.com Daily Mail and Mail on Sunday newspapers.
Two CU Cancer Center studies provide insights into the link between inflammation and leukemia
Two recent collaborative publications by CU Cancer Center members provide insights into how chronic inflammation can serve as a key factor in the development of leukemia and other blood cancers.
Eric Pietras, Ph.D., CU Cancer Center member and assistant professor in the CU School of Medicine Division of Hematology, and James DeGregori, Ph.D., deputy director of the CU Cancer Center and professor in the Department of Biochemistry and Molecular Genetics, were corresponding authors on both papers.
Both papers provide support for the theory of adaptive oncogenesis, which was developed by DeGregori. The theory stipulates that chronic inflammation (such as the inflammation associated with aging or with chronic disease) reduces the fitness of normal cells, hindering their ability to reproduce and creating space for cells with cancer-causing mutations to proliferate.
/ Colorado residents over the age of 18 will be automatically eligible for all five chances to win $1 million if they get their first dose by Friday.
You may be familiar with the TV show “Who Wants To Be A Millionaire?” Colorado has launched its own version, and all residents who are vaccinated against COVID-19 are eligible to win. The state
announced it will give away $1 million weekly between June 4 and July 7, using federal CARES Act money that would have gone to vaccine advertising. But how well vaccine incentives actually work remains a bit of an open question.
“Colorado, every vaccine works incredibly well,” Gov. Jared Polis said during the Tuesday press conference where he announced the sweepstakes. He pointed to the Pfizer/BioNTech vaccine’s
Sensyne Health Signs Strategic Research Agreement with the Colorado Center for Personalized Medicine
New agreement covering 7.3 million patients brings Sensyne’s combined total dataset of anonymised and de-identified patient data for medical research to 18.2 million patients
Second U.S. Strategic Research Agreement by clinical AI pioneer Sensyne to enable the ethical application of clinical AI to improve patient care and accelerate medical research
Oxford, U.K, and Dover, Delaware, USA 24 May 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI company, today announces that it has signed its second Strategic Research Agreement (“SRA”) in the U.S. with the Colorado Center for Personalized Medicine (“CCPM”), a partnership between non-profit health system UCHealth and the University of Colorado Anschutz Medical Campus.
Moderna Vaccine Highly Effective in Adolescents, Company Says
The U.S., which has a surplus of vaccines, could soon have two options for teens while many countries face shortages.
A teen participant in the Moderna vaccine trial received a shot in Houston in February.Credit.Brandon Thibodeaux for The New York Times
By Emily Anthes
May 25, 2021Updated 6:10 p.m. ET
Moderna said on Tuesday that its coronavirus vaccine, authorized only for use in adults, was powerfully effective in 12- to 17-year-olds. In a clinical trial of the vaccine in adolescents, there were no cases of symptomatic Covid-19 among fully vaccinated teens, the company reported in a news release.